BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 32945944)

  • 21. COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19).
    Scirè CA; Carrara G; Zanetti A; Landolfi G; Chighizola C; Alunno A; Andreoli L; Caporali R; Gerli R; Sebastiani GD; Valesini G; Sinigaglia L;
    Clin Exp Rheumatol; 2020; 38(4):748-753. PubMed ID: 32723435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary Estimate of Excess Mortality During the COVID-19 Outbreak - New York City, March 11-May 2, 2020.
    New York City Department of Health and Mental Hygiene (DOHMH) COVID-19 Response Team
    MMWR Morb Mortal Wkly Rep; 2020 May; 69(19):603-605. PubMed ID: 32407306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics and Outcomes of 241 Births to Women With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection at Five New York City Medical Centers.
    Khoury R; Bernstein PS; Debolt C; Stone J; Sutton DM; Simpson LL; Limaye MA; Roman AS; Fazzari M; Penfield CA; Ferrara L; Lambert C; Nathan L; Wright R; Bianco A; Wagner B; Goffman D; Gyamfi-Bannerman C; Schweizer WE; Avila K; Khaksari B; Proehl M; Heitor F; Monro J; Keefe DL; D'Alton ME; Brodman M; Makhija SK; Dolan SM
    Obstet Gynecol; 2020 Aug; 136(2):273-282. PubMed ID: 32555034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of clinical characteristics between coronavirus disease 2019 pneumonia and community-acquired pneumonia.
    Tian J; Xu Q; Liu S; Mao L; Wang M; Hou X
    Curr Med Res Opin; 2020 Nov; 36(11):1747-1752. PubMed ID: 32986475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
    Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
    Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.
    Ferguson J; Rosser JI; Quintero O; Scott J; Subramanian A; Gumma M; Rogers A; Kappagoda S
    Emerg Infect Dis; 2020 Aug; 26(8):1679-1685. PubMed ID: 32407284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.
    Jeong TH; Pak C; Ock M; Lee SH; Son JS; Jeon YJ
    J Korean Med Sci; 2020 Sep; 35(37):e333. PubMed ID: 32959547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease.
    Kow CS; Hasan SS
    Rheumatol Int; 2020 Dec; 40(12):2117-2118. PubMed ID: 33044704
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
    Yang K; Sheng Y; Huang C; Jin Y; Xiong N; Jiang K; Lu H; Liu J; Yang J; Dong Y; Pan D; Shu C; Li J; Wei J; Huang Y; Peng L; Wu M; Zhang R; Wu B; Li Y; Cai L; Li G; Zhang T; Wu G
    Lancet Oncol; 2020 Jul; 21(7):904-913. PubMed ID: 32479787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Features and Outcomes of 98 Patients Hospitalized with SARS-CoV-2 Infection in Daegu, South Korea: A Brief Descriptive Study.
    Hong KS; Lee KH; Chung JH; Shin KC; Choi EY; Jin HJ; Jang JG; Lee W; Ahn JH
    Yonsei Med J; 2020 May; 61(5):431-437. PubMed ID: 32390367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial.
    Dastan F; Saffaei A; Haseli S; Marjani M; Moniri A; Abtahian Z; Abedini A; Kiani A; Seifi S; Jammati H; Hashemian SMR; Pourabdollah Toutkaboni M; Eslaminejad A; Heshmatnia J; Sadeghi M; Nadji SA; Dastan A; Baghaei P; Varahram M; Yousefian S; Salamzadeh J; Tabarsi P
    Int Immunopharmacol; 2020 Nov; 88():106869. PubMed ID: 32889241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID-19) from Zhejiang province in China.
    Lian J; Jin X; Hao S; Jia H; Cai H; Zhang X; Hu J; Zheng L; Wang X; Zhang S; Ye C; Jin C; Yu G; Gu J; Lu Y; Yu X; Xiang D; Li L; Liang T; Sheng J; Yang Y
    Influenza Other Respir Viruses; 2020 Sep; 14(5):564-574. PubMed ID: 32397011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Characteristics and Outcomes of Older Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: A Single-Centered, Retrospective Study.
    Chen T; Dai Z; Mo P; Li X; Ma Z; Song S; Chen X; Luo M; Liang K; Gao S; Zhang Y; Deng L; Xiong Y
    J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(9):1788-1795. PubMed ID: 32279081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics of coronavirus disease 2019 in Gansu province, China.
    Yue H; Bai X; Wang J; Yu Q; Liu W; Pu J; Wang X; Hu J; Xu D; Li X; Kang N; Li L; Lu W; Feng T; Ding L; Li X; Qi X;
    Ann Palliat Med; 2020 Jul; 9(4):1404-1412. PubMed ID: 32692208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extending rituximab dosing intervals in patients with MS during the COVID-19 pandemic and beyond?
    Maarouf A; Rico A; Boutiere C; Perriguey M; Demortiere S; Pelletier J; Audoin B;
    Neurol Neuroimmunol Neuroinflamm; 2020 Sep; 7(5):. PubMed ID: 32587103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.
    Chen Y; Chen L; Deng Q; Zhang G; Wu K; Ni L; Yang Y; Liu B; Wang W; Wei C; Yang J; Ye G; Cheng Z
    J Med Virol; 2020 Jul; 92(7):833-840. PubMed ID: 32243607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV2) patients in Hospital Tengku Ampuan Afzan.
    Soh TV; Dzawani M; Noorlina N; Nik F; Norazmi A
    Med J Malaysia; 2020 Sep; 75(5):479-484. PubMed ID: 32918413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.
    Ferri C; Giuggioli D; Raimondo V; L'Andolina M; Tavoni A; Cecchetti R; Guiducci S; Ursini F; Caminiti M; Varcasia G; Gigliotti P; Pellegrini R; Olivo D; Colaci M; Murdaca G; Brittelli R; Mariano GP; Spinella A; Bellando-Randone S; Aiello V; Bilia S; Giannini D; Ferrari T; Caminiti R; Brusi V; Meliconi R; Fallahi P; Antonelli A;
    Clin Rheumatol; 2020 Nov; 39(11):3195-3204. PubMed ID: 32852623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
    Freites Nuñez DD; Leon L; Mucientes A; Rodriguez-Rodriguez L; Font Urgelles J; Madrid García A; Colomer JI; Jover JA; Fernandez-Gutierrez B; Abasolo L
    Ann Rheum Dis; 2020 Nov; 79(11):1393-1399. PubMed ID: 32769150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of COVID-19 disease severity in patients with cancer.
    Robilotti EV; Babady NE; Mead PA; Rolling T; Perez-Johnston R; Bernardes M; Bogler Y; Caldararo M; Figueroa CJ; Glickman MS; Joanow A; Kaltsas A; Lee YJ; Lucca A; Mariano A; Morjaria S; Nawar T; Papanicolaou GA; Predmore J; Redelman-Sidi G; Schmidt E; Seo SK; Sepkowitz K; Shah MK; Wolchok JD; Hohl TM; Taur Y; Kamboj M
    Nat Med; 2020 Aug; 26(8):1218-1223. PubMed ID: 32581323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.